ResearcherUniversity of Colorado Cancer CenterNo recent work listed
Sarah Lindsey Davis
Matched on ORCID iD 0000-0003-3899-9481; OpenAlex author ID A5006135708. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers
Papers 4
- Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Co-author DOI 10.1093/bjs/znab092↗
- WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.642328↗
- A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated … Co-author DOI 10.1007/s10637-019-00824-1↗
- Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database. Co-author DOI 10.1097/mpa.0000000000000876↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wells A. Messersmith · 4 shared papers, 2017–2021 · strength 0.38
- Paper WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ducta… DOI 10.3389/fonc.2021.642328↗
- Paper A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabin… DOI 10.1007/s10637-019-00824-1↗
- Paper Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. DOI 10.1093/bjs/znab092↗
- Christopher Hanyoung Lieu · 3 shared papers, 2017–2021 · strength 0.28
- Paper WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ducta… DOI 10.3389/fonc.2021.642328↗
- Paper Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. DOI 10.1093/bjs/znab092↗
- Paper Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database. DOI 10.1097/mpa.0000000000000876↗
- Alexis Diane Leal · 2 shared papers, 2021 · strength 0.21
- Paper WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ducta… DOI 10.3389/fonc.2021.642328↗
- Paper Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. DOI 10.1093/bjs/znab092↗
- Karyn A. Goodman · 2 shared papers, 2017–2021 · strength 0.16
- Stephen Leong · 2 shared papers, 2017–2021 · strength 0.16
- Todd M. Pitts · 1 shared paper, 2021 · strength 0.12
- Sarah J. Hartman · 1 shared paper, 2021 · strength 0.12
- Safi Shahda · 1 shared paper, 2020 · strength 0.11
- Bert H. O’Neil · 1 shared paper, 2020 · strength 0.11
- Efrat Dotan · 1 shared paper, 2020 · strength 0.11
- Heinz‐Josef Lenz · 1 shared paper, 2020 · strength 0.11
- Dana Backlund Cardin · 1 shared paper, 2020 · strength 0.11
- Jordan D. Berlin · 1 shared paper, 2020 · strength 0.11
- Steven J. Cohen · 1 shared paper, 2020 · strength 0.11
- Ana Gleisner · 1 shared paper, 2021 · strength 0.10
- Atsushi Oba · 1 shared paper, 2021 · strength 0.10
- Yuki Fujiwara · 1 shared paper, 2021 · strength 0.10
- Sana D. Karam · 1 shared paper, 2021 · strength 0.10
- Marco Del Chiaro · 1 shared paper, 2021 · strength 0.10
- Richard David Schulick · 1 shared paper, 2021 · strength 0.10
- Bernard L. Jones · 1 shared paper, 2017 · strength 0.06
- Arya Amini · 1 shared paper, 2017 · strength 0.06
- Colin D. Weekes · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.